JPWO2020246120A1 - - Google Patents

Info

Publication number
JPWO2020246120A1
JPWO2020246120A1 JP2021524680A JP2021524680A JPWO2020246120A1 JP WO2020246120 A1 JPWO2020246120 A1 JP WO2020246120A1 JP 2021524680 A JP2021524680 A JP 2021524680A JP 2021524680 A JP2021524680 A JP 2021524680A JP WO2020246120 A1 JPWO2020246120 A1 JP WO2020246120A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021524680A
Other languages
Japanese (ja)
Other versions
JP7360460B2 (en
JPWO2020246120A5 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020246120A1 publication Critical patent/JPWO2020246120A1/ja
Publication of JPWO2020246120A5 publication Critical patent/JPWO2020246120A5/ja
Application granted granted Critical
Publication of JP7360460B2 publication Critical patent/JP7360460B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
JP2021524680A 2019-06-07 2020-03-30 Orally disintegrating tablet and its manufacturing method Active JP7360460B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019106806 2019-06-07
JP2019106806 2019-06-07
PCT/JP2020/014429 WO2020246120A1 (en) 2019-06-07 2020-03-30 Orally disintegrating tablet and manufacturing method therefor

Publications (3)

Publication Number Publication Date
JPWO2020246120A1 true JPWO2020246120A1 (en) 2020-12-10
JPWO2020246120A5 JPWO2020246120A5 (en) 2022-05-19
JP7360460B2 JP7360460B2 (en) 2023-10-12

Family

ID=73653120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021524680A Active JP7360460B2 (en) 2019-06-07 2020-03-30 Orally disintegrating tablet and its manufacturing method

Country Status (2)

Country Link
JP (1) JP7360460B2 (en)
WO (1) WO2020246120A1 (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1271997A (en) * 1999-04-27 2000-11-01 富士电机株式会社 Noise inhibiting wave filter
JP3389205B2 (en) * 1999-06-29 2003-03-24 武田薬品工業株式会社 Oral quick disintegrating tablets
WO2005123040A1 (en) * 2004-06-22 2005-12-29 Shionogi & Co., Ltd. Tablet rapidly disintegrating in mouth
JP2010106014A (en) * 2008-10-01 2010-05-13 Taisho Pharmaceutical Co Ltd Acetaminophen-containing tablet
JP4719899B2 (en) * 2000-01-07 2011-07-06 大正製薬株式会社 Orally rapidly disintegrating tablets
JP2011157348A (en) * 2010-01-05 2011-08-18 Fuji Chem Ind Co Ltd Disintegrable high-strength spherical particle composition
WO2013146917A1 (en) * 2012-03-29 2013-10-03 株式会社ダイセル Method for producing disintegrating particulate composition comprising acid-type carboxymethylcellulose, disintegrating particulate composition comprising acid-type carboxymethylcellulose, and orally disintegrating tablet including disintegrating particulate composition comprising acid-type carboxymethylcellulose
JP2017002045A (en) * 2015-06-12 2017-01-05 ゼリア新薬工業株式会社 Orally disintegrating tablet
WO2017195796A1 (en) * 2016-05-10 2017-11-16 日本臓器製薬株式会社 Method for manufacturing acetaminophen preparation
JP6496084B2 (en) * 2016-06-16 2019-04-03 東和薬品株式会社 Orally disintegrating tablets

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1271997C (en) * 2004-02-27 2006-08-30 石药集团中奇制药技术（石家庄）有限公司 Oral disintegration tablets contg. p-acetaminophenol, and prepn. method therefor
JP5575119B2 (en) * 2009-05-20 2014-08-20 大日本住友製薬株式会社 Orally disintegrating tablets
WO2013047353A1 (en) * 2011-09-26 2013-04-04 日本曹達株式会社 Orally disintegrating tablet containing hydroxyalkyl cellulose fine particles
JP6832753B2 (en) * 2017-03-09 2021-02-24 旭化成株式会社 Cellulose complex

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1271997A (en) * 1999-04-27 2000-11-01 富士电机株式会社 Noise inhibiting wave filter
JP3389205B2 (en) * 1999-06-29 2003-03-24 武田薬品工業株式会社 Oral quick disintegrating tablets
JP4719899B2 (en) * 2000-01-07 2011-07-06 大正製薬株式会社 Orally rapidly disintegrating tablets
WO2005123040A1 (en) * 2004-06-22 2005-12-29 Shionogi & Co., Ltd. Tablet rapidly disintegrating in mouth
JP2010106014A (en) * 2008-10-01 2010-05-13 Taisho Pharmaceutical Co Ltd Acetaminophen-containing tablet
JP2011157348A (en) * 2010-01-05 2011-08-18 Fuji Chem Ind Co Ltd Disintegrable high-strength spherical particle composition
WO2013146917A1 (en) * 2012-03-29 2013-10-03 株式会社ダイセル Method for producing disintegrating particulate composition comprising acid-type carboxymethylcellulose, disintegrating particulate composition comprising acid-type carboxymethylcellulose, and orally disintegrating tablet including disintegrating particulate composition comprising acid-type carboxymethylcellulose
JP2017002045A (en) * 2015-06-12 2017-01-05 ゼリア新薬工業株式会社 Orally disintegrating tablet
WO2017195796A1 (en) * 2016-05-10 2017-11-16 日本臓器製薬株式会社 Method for manufacturing acetaminophen preparation
JP6496084B2 (en) * 2016-06-16 2019-04-03 東和薬品株式会社 Orally disintegrating tablets

Also Published As

Publication number Publication date
WO2020246120A1 (en) 2020-12-10
JP7360460B2 (en) 2023-10-12

Similar Documents

Publication Publication Date Title
BR112019017762A2 (en)
BR112021017339A2 (en)
BR112021018450A2 (en)
BR112021013854A2 (en)
BR112021017939A2 (en)
BR112021017892A2 (en)
BR112019016141A2 (en)
AU2020104490A4 (en)
BR112021017738A2 (en)
BR112021017782A2 (en)
BR112019016142A2 (en)
BR112019016138A2 (en)
BR112021018168A2 (en)
BR112021017234A2 (en)
BR112021017355A2 (en)
BR112021017173A2 (en)
BR112021018102A2 (en)
BR112021017728A2 (en)
BR112021017083A2 (en)
BR112021017637A2 (en)
BR112021008711A2 (en)
BR112021018452A2 (en)
BR112021012348A2 (en)
BR112021018250A2 (en)
BR112021018084A2 (en)

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A5211

Effective date: 20211129

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20220517

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220518

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221101

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230905

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230929

R150 Certificate of patent or registration of utility model

Ref document number: 7360460

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150